ReviewFrontiers in pharmacology2025
Regulation of pyroptosis by natural products in atherosclerosis: mechanisms and therapeutic potential.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pyroptosis, a proinflammatory form of programmed cell death characterized by inflammasome activation and gasdermin-mediated membrane pore formation, has been recognized as a critical contributor to the initiation and progression of atherosclerosis (AS). Increasing evidence indicates that pyroptosis accelerates plaque formation and rupture by promoting endothelial dysfunction, vascular smooth muscle cell loss, and destabilization of macrophage-derived foam cells. Given its pivotal role in AS pathogenesis, modulation of pyroptotic signaling pathways is considered a highly promising therapeutic strategy. Natural products derived from medicinal plants and dietary sources possess multiple biological activities, including antioxidant, anti-inflammatory, and lipid-regulating effects, and their potential to target pyroptosis in cardiovascular diseases has attracted growing attention in recent years. This review systematically summarizes current advances in understanding the regulatory effects of natural products on pyroptosis in AS. Representative compounds, including polyphenols, flavonoids, saponins, and alkaloids, have been shown in AS animal models to inhibit inflammasome assembly, block gasdermin cleavage, and restore vascular homeostasis. This review focuses on elucidating the mechanisms and therapeutic potential of natural products in regulating pyroptosis in AS, aiming to provide a reference for their application in AS treatment and to lay a foundation for the development of effective new drugs for AS prevention and management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.